Kakuya Niihata:
ORCID: http://orcid.org/0000-0001-9836-5750
Role: ConceptualizationRole: Formal analysisRole: Writing – original draft
Shingo Fukuma: Role: Formal analysisRole: Project administrationRole: Writing – original draft
Tadao Akizawa: Role: SupervisionRole: Writing – review & editing
Shunichi Fukuhara: Role: SupervisionRole: Writing – review & editing
Joseph Chilcot: Role: Editor
Journal ID (nlm-ta): PLoS One
Journal ID (iso-abbrev): PLoS ONE
Journal ID (publisher-id): plos
Journal ID (pmc): plosone
Title:
PLoS ONE
Publisher:
Public Library of Science
(San Francisco, CA USA
)
ISSN
(Electronic):
1932-6203
Publication date
(Electronic):
25
July
2017
Publication date Collection: 2017
Volume: 12
Issue: 7
Electronic Location Identifier: e0180498
Affiliations
[1
]
Division of Clinical Epidemiology, Fukushima Medical University, Fukushima, Japan
[2
]
Center for Innovative Research for Communities and Clinical Excellence (CIRC
2LE), Fukushima Medical University, Fukushima, Japan
[3
]
Department of Healthcare and Epidemiology, School of Public Health, Kyoto University
of Medicine, Kyoto, Japan
[4
]
Institute for Health Outcomes and Process Evaluation Research (iHope International),
Kyoto, Japan
[5
]
Division of Nephrology, Department of Medicine, Showa University School of Medicine,
Tokyo, Japan
King's College London, UNITED KINGDOM
Author notes
Competing Interests: This study was supported by Kyowa Hakko Kirin. Niihata K. has nothing additional to
disclose. Fukuma S. has acted as a scientific advisor to Kyowa Hakko Kirin. Fukuhara
S. has acted as a scientific advisor to and received grants from Kyowa Hakko Kirin.
Akizawa T. has consultancy agreements with Astellas Pharma, AbbVie, Kyowa Hakko Kirin,
Bayer HealthCare Pharmaceuticals, GlaxoSmithKline, JT Pharmaceuticals Corporate, Kissei
Pharmaceutical, Nipro Medical Corporation, Ono Pharmaceutical, and is a member of
the Astellas’ advisory panel. Akizawa T. is also a scientific advisor of Bayer HealthCare
Pharmaceuticals and a member of the speaker’s bureau of Bayer HealthCare Pharmaceuticals,
Kyowa Hakko Kirin, Chugai Pharmaceutical, Torii Pharmaceutical, Fuso Pharmaceutical
Industries, and Teijin Pharma. The DOPPS program is supported by Amgen, Kyowa Hakko
Kirin, AbbVie Inc, Sanofi Renal, Baxter Healthcare, and Vifor Fresenius Medical Care
Renal Pharma Ltd. Additional support for specific projects and countries is also provided
in Canada by Amgen, BHC Medical, Janssen, Takeda, and Kidney Foundation of Canada
(for logistics support); in Germany by Hexal, DGfN, Shire, and WiNe Institute; and
for Peritoneal DOPPS (PDOPPS) in Japan by the Japanese Society for Peritoneal Dialysis
(JSPD). All support is provided without restrictions on publications. These affiliations
do not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.
Author information
Article
Publisher ID:
PONE-D-16-25993
DOI: 10.1371/journal.pone.0180498
PMC ID: 5526523
PubMed ID: 28742807
SO-VID: fce89b46-5552-4cfb-8cd5-5d7f5da23aca
Copyright © © 2017 Niihata et al
License:
This is an open access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided
the original author and source are credited.
This study was supported by Kyowa Hakko Kirin. The funder had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Subject:
Research Article
Subject:
Medicine and Health Sciences
Subject:
Nephrology
Subject:
Medical Dialysis
Subject:
Medicine and Health Sciences
Subject:
Mental Health and Psychiatry
Subject:
Medicine and Health Sciences
Subject:
Mental Health and Psychiatry
Subject:
Psychological Stress
Subject:
Biology and Life Sciences
Subject:
Psychology
Subject:
Psychological Stress
Subject:
Social Sciences
Subject:
Psychology
Subject:
Psychological Stress
Subject:
Biology and Life Sciences
Subject:
Anatomy
Subject:
Renal System
Subject:
Kidneys
Subject:
Medicine and Health Sciences
Subject:
Anatomy
Subject:
Renal System
Subject:
Kidneys
Subject:
Medicine and Health Sciences
Subject:
Cardiovascular Medicine
Subject:
Cardiovascular Diseases
Subject:
Medicine and Health Sciences
Subject:
Endocrinology
Subject:
Endocrine Disorders
Subject:
Diabetes Mellitus
Subject:
Medicine and Health Sciences
Subject:
Metabolic Disorders
Subject:
Diabetes Mellitus
Subject:
Medicine and Health Sciences
Subject:
Health Care
Subject:
Quality of Life
Subject:
Medicine and Health Sciences
Subject:
Public and Occupational Health